Insights

Gathering insights about ProQR Therapeutics…

Similar companies to ProQR Therapeutics

ProQR Therapeutics Tech Stack

ProQR Therapeutics uses 8 technology products and services including WordPress Super Cache, SAP, Google Font API, and more. Explore ProQR Therapeutics's tech stack below.

WordPress Super Cache
Caching
SAP
Customer Relationship Management
Google Font API
Font Scripts
ADP HRMS
Human Resource Management System
Lightbox
Javascript Libraries
X-Content-Type-Options
Miscellaneous
Yoast SEO
Search Engines
Google Tag Manager
Tag Management

Media & News

ProQR Therapeutics's Email Address Formats

ProQR Therapeutics uses at least 1 format(s):

ProQR Therapeutics Email Formats	Example	Percentage
FLast@proqr.com	JDoe@proqr.com	61%
First.Last@proqr.com	John.Doe@proqr.com	33%
FMiddleLast@proqr.com	JMichaelDoe@proqr.com	4%
Last_First@proqr.com	Doe_John@proqr.com	2%

Frequently Asked Questions

Where is ProQR Therapeutics's headquarters located?

ProQR Therapeutics's main headquarters is located at Zernikedreef 9 Leiden, Zuid-Holland 2333CK NL. The company has employees across 2 continents, including EuropeNorth America.

What is ProQR Therapeutics's phone number?

You can contact ProQR Therapeutics's main corporate office by phone at

+31-88-166-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ProQR Therapeutics's stock symbol?

ProQR Therapeutics is a publicly traded company; the company's stock symbol is PRQR.

What is ProQR Therapeutics's official website and social media links?

ProQR Therapeutics's official website is proqr.com and has social profiles on LinkedIn.

How much revenue does ProQR Therapeutics generate?

As of November 2024, ProQR Therapeutics's annual revenue reached $35M.

What is ProQR Therapeutics's SIC code NAICS code?

ProQR Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ProQR Therapeutics have currently?

As of November 2024, ProQR Therapeutics has approximately 179 employees across 2 continents, including EuropeNorth America. Key team members include Chief People & Operations Officer: S. S.Chief Financial Officer (cfo): J. D.Chief Corporate Development Officer & General Counsel: R. B.. Explore ProQR Therapeutics's employee directory with LeadIQ.

What industry does ProQR Therapeutics belong to?

ProQR Therapeutics operates in the Biotechnology Research industry.

What technology does ProQR Therapeutics use?

ProQR Therapeutics's tech stack includes WordPress Super CacheSAPGoogle Font APIADP HRMSLightboxX-Content-Type-OptionsYoast SEOGoogle Tag Manager.

What is ProQR Therapeutics's email format?

ProQR Therapeutics's email format typically follows the pattern of . Find more ProQR Therapeutics email formats with LeadIQ.

How much funding has ProQR Therapeutics raised to date?

As of November 2024, ProQR Therapeutics has raised $75M in funding. The last funding round occurred on Oct 22, 2024 for $75M.

When was ProQR Therapeutics founded?

ProQR Therapeutics was founded in 2012.

ProQR Therapeutics

Biotechnology ResearchZuid-Holland, Netherlands51-200 Employees

Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary Axiomer™  RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them.

If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/

Company Overview

Headquarters: Zernikedreef 9 Leiden, Zuid-Holland 2333CK NL
Phone number: ✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+31-88-166-****
Website: proqr.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: PRQR
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2012
Employees: 51-200

Media & News

Funding & Financials

$75M
ProQR Therapeutics has raised a total of $75M of funding over 10 rounds. Their latest funding round was raised on Oct 22, 2024 in the amount of $75M.
$10M$50M
ProQR Therapeutics's revenue is in the range of $10M$50M

Funding & Financials

$75M
ProQR Therapeutics has raised a total of $75M of funding over 10 rounds. Their latest funding round was raised on Oct 22, 2024 in the amount of $75M.
$10M$50M
ProQR Therapeutics's revenue is in the range of $10M$50M

Company Leadership

S. S.
Chief People & Operations Officer
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. D.
Chief Financial Officer (cfo)
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. B.
Chief Corporate Development Officer & General Counsel
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
V. A.
Vice President - Chief Of Staff To The Ceo
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. D. B.
Vice President Nonclinical R&d
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. C.
Personal Assistant To Ceo
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. B.
Chief Corporate Development Officer & General Counsel
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. B.
Head Of Regulatory Affairs And Early Development Project Lead
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. M.
Vp Business Development
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. O.
Vp Scientific Operations
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for ProQR Therapeutics and Millions of Other Companies
Sign up for full access to ProQR Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to ProQR Therapeutics

Vertex Pharmaceuticals

Exonics Therapeutics

Cytokinetics

Editas Medicine

Arcturus Therapeutics

Beam Therapeutics

LogicBio Therapeutics

Alnylam Pharmaceuticals

ProQR Therapeutics Tech Stack

Media & News

RFG Advisory, LLC invests into ProQR Therapeutics NV $73K.

ProQR Therapeutics NV launches preclinical data for proprietary Axiomer RNA editing technology platform, including the first preclinical proof of concept data for AX-0810 pipeline program for cholestatic diseases targeting NTCP.

ProQR Therapeutics NV launches Japanese Axiomer patent upheld.

ProQR Therapeutics NV is developing therapies for central nervous system diseases.

ProQR Therapeutics NV partners with Rett Syndrome Research Trust.

ProQR Therapeutics NV receives financing of $1M in research grant.

ProQR Therapeutics NV partners with Axiomer.

ProQR Therapeutics's Email Address Formats

Frequently Asked Questions

Where is ProQR Therapeutics's headquarters located?

What is ProQR Therapeutics's phone number?

What is ProQR Therapeutics's stock symbol?

What is ProQR Therapeutics's official website and social media links?

How much revenue does ProQR Therapeutics generate?

What is ProQR Therapeutics's SIC code NAICS code?

How many employees does ProQR Therapeutics have currently?

What industry does ProQR Therapeutics belong to?

What technology does ProQR Therapeutics use?

What is ProQR Therapeutics's email format?

How much funding has ProQR Therapeutics raised to date?

When was ProQR Therapeutics founded?

ProQR Therapeutics

Company Overview

Media & News

RFG Advisory, LLC invests into ProQR Therapeutics NV $73K.

ProQR Therapeutics NV launches preclinical data for proprietary Axiomer RNA editing technology platform, including the first preclinical proof of concept data for AX-0810 pipeline program for cholestatic diseases targeting NTCP.

ProQR Therapeutics NV launches Japanese Axiomer patent upheld.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?